Actively Recruiting

Phase Not Applicable
Age: 8Years +
All Genders
Healthy Volunteers
ID05744310

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

Led by Haukeland University Hospital · Updated on 2025-08-28

200

Participants Needed

9

Research Sites

N/A

Total Duration

On this page

Sponsors

H

Haukeland University Hospital

Lead Sponsor

O

Oslo University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Amyotrophic lateral sclerosis (ALS) is a severe and rapidly progressing nervous system disease with an average survival of two to three years after diagnosis. Patients experience significant physical and psychological challenges, and apart from the drug Riluzole, effective treatments are lacking. This study aims to understand how life-sustaining ventilation support, either non-invasive or with tracheostomy, impacts the quality of life of ALS patients, their partners, and children, addressing a difficult ethical issue in ALS care. Participants are divided into two groups: those who choose life-prolonging treatment with long-term mechanical ventilation support and those who decline such treatment. The study involves a longitudinal questionnaire approach conducted in Norway, measuring overall, health-related, and disease-specific quality of life over time. Assessments occur at inclusion and then every three months up to 21 months. Throughout the study, ALS patients, their partners, and children complete various quality of life questionnaires, including the Quality of Life Scale, EQ-5D-5L, ALS-specific scales, and caregiver burden surveys. Researchers monitor changes in these assessments to understand the effects of ventilation support. The study is sponsored by Haukeland University Hospital and includes participants aged 8 years and older, with data collection planned until 2032.

CONDITIONS

Brief Title

Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families

Who Can Participate

Age: 8Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • A clinical diagnosis of probable ALS according to the revised El Escorial criteria
  • Illness progression leading the consulting physician to offer treatment with long-term mechanical ventilation support
  • Ability to communicate in Norwegian
  • Partners of ALS patients meeting the above criteria
  • Children aged 8 years or older with a parent who has ALS and meets the above criteria
Not Eligible

You will not qualify if you...

  • Cognitive impairment or dementia in patients, partners, or children of ALS patients
  • Inability to communicate in Norwegian
  • Age below 8 years for children participating
  • Not meeting diagnostic or disease progression criteria for ALS patients
  • Not being a partner or child of an eligible ALS patient

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 21 months

Participants either receive long term mechanical ventilation support or decline this treatment as part of their care.

Assessments at inclusion, and at 3, 9, 15, and 21 months after inclusion

Trial Site Locations

Total: 9 locations

1

Nordland Hospital Bodø

Bodø, Nordland, Norway, 8005

Actively Recruiting

2

Sørlandet Hospital Trust

Kristiansand, Vest Agder, Norway

Actively Recruiting

3

Haukeland University Hospital

Bergen, Norway

Actively Recruiting

4

Akershus University Hospital

Lørenskog, Norway

Actively Recruiting

5

Oslo University Hospital

Oslo, Norway

Actively Recruiting

6

Østfold Hospital Kalnes

Sarpsborg, Norway, 1714

Not Yet Recruiting

7

Stavanger University Hospital

Stavanger, Norway

Actively Recruiting

8

Universitetssykehuset Nord-Norge

Tromsø, Norway

Actively Recruiting

9

St. Olavs Hospital

Trondheim, Norway

Actively Recruiting

Loading map...

Research Team

O

Ole-Bjørn Tysnes

T

Tale Litlere Bjerknes

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Phase 1 Study to Evaluate [18F]ACI-19626 as a PET Radioligan...

Frontotemporal Dementia (FTD)

Actively Recruiting

1 location

A Low-Cost Balance Training Platform Using Augmented Reality...

Postural Balance

Actively Recruiting

1 location

A Multi-domain Lifestyle Intervention Among Aged Community-r...

Cognitive Impairment

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here